Wei Zhang
Director of Finance/CFO at CASI PHARMACEUTICALS, INC.
Net worth: 4 635 $ as of 2024-04-29
Network origin in Wei Zhang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wei Zhang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MARSH & MCLENNAN COMPANIES | Insurance Brokers/Services | Corporate Officer/Principal | |
| 3SBIO INC. | Biotechnology | Corporate Officer/Principal | |
| SCHNEIDER ELECTRIC SE | Electrical Products | Human Resources Officer | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree | |
| VCANBIO CELL & GENE ENGINEERING CORP., LTD | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago | College/University | Masters Business Admin | |
Emerging Technology Partners LLC
 Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California. | Investment Managers | Founder | |
| University of California, Berkeley | College/University | Doctorate Degree | |
PricewaterhouseCoopers Zhong Tian LLP
 PricewaterhouseCoopers Zhong Tian LLP Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Zhong Tian LLP provides accounting services. The company is based in Shanghai, China. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| Jilin University | College/University | Undergraduate Degree | |
| Fudan University | College/University | Undergraduate Degree | |
| Northeastern University (China) | College/University | Undergraduate Degree | |
| University of International Business & Economics | College/University | Undergraduate Degree | |
| Renmin University of China | College/University | Masters Business Admin Graduate Degree | |
Chiral Quest (Suzhou) Co., Ltd.
 Chiral Quest (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chiral Quest (Suzhou) Co. Ltd. provides drug discovery services. It focuses on the development and manufacture of chiral catalysts, development of synthetic processes, and a technology applications platform. Its products include a, b, and Cyclicb-amino acids; b-hydroxy acids; chiral amines, alcohols, amino alcohols, and pyrrolidines; succinates; and achiral compounds, a-hydroxy acids, and APIs and intermediates. Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. The company was founded by Xumu Zhang in 2000 and is headquartered in Suzhou, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Starvax, Inc. | Corporate Officer/Principal | ||
Shenzhen Investment Holdings Co., Ltd.
 Shenzhen Investment Holdings Co., Ltd. Financial ConglomeratesFinance Shenzhen Investment Holdings Co., Ltd. operates as a state-owned asset management company. Its business activities include management of properties, capital operation, investment and financing, transportation logistics, manufacturing and trading, and modern service industries. The company was founded on October 13, 2004 and is headquartered in Shenzhen, China. | Financial Conglomerates | Corporate Officer/Principal | |
J. Craig Venter Institute, Inc.
 J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| Hisanaga Seisakusho Co. Ltd. | Director/Board Member | ||
| Sun Yat-Sen University | College/University | Graduate Degree | |
| Hebei Medical University | College/University | Undergraduate Degree | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Chairman | |
Polyrey Medical Tech (Suzhou) Co., Ltd.
 Polyrey Medical Tech (Suzhou) Co., Ltd. Medical SpecialtiesHealth Technology Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China. | Medical Specialties | Director/Board Member | |
| Qinghai Nationalities University | College/University | Undergraduate Degree | |
Mundipharma (China) Pharmaceutical Co., Ltd.
 Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Beijing, China. | Pharmaceuticals: Major | Sales & Marketing | |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Shandong Bestcomm Pharmaceutical Co., Ltd.
 Shandong Bestcomm Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shandong Bestcomm Pharmaceutical Co., Ltd. is engaged in the research, development and production of domestic pharmaceutical technology. It also offers the development of various new drugs. The company was founded on August 2, 2000 and is headquartered in Jinan, China. | Miscellaneous Commercial Services | Director/Board Member | |
Hangzhou Sciwind Biosciences Co., Ltd.
 Hangzhou Sciwind Biosciences Co., Ltd. BiotechnologyHealth Technology Hangzhou Sciwind Biosciences Co., Ltd. is a biopharmaceutical company based in Hangzhou, China. The Chinese company's product pipeline includes potentially first-in-class and drug candidates, such as the long-acting glp-1 peptide analog ecnoglutide (phase 3), oral glp-1 peptide analog xw004 (phase 1), and oral small molecule glp-1 receptor agonist xw014 (phase 1). Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms, and identified a series of drug candidates based on these core platform technologies. The company was founded in 2017 by Hai Pan, who has been the CEO since 2017. | Biotechnology | Director/Board Member | |
| WANDA SPORTS GROUP COMPANY LIMITED | Movies/Entertainment | Comptroller/Controller/Auditor | |
| GENETRON HOLDINGS LIMITED | Medical/Nursing Services | Founder Director/Board Member | |
| Guangdong Medical University | College/University | Undergraduate Degree | |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Pharmaceuticals: Major | Founder Founder | |
| TCRCcure Biopharma Ltd. | Director/Board Member | ||
| Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | ||
| Meyer FSMP Hong Kong Ltd. | Director/Board Member | ||
Guazi.com, Inc.
 Guazi.com, Inc. Specialty StoresRetail Trade Guazi.com, Inc. provides a platform for trading used cars. | Specialty Stores | Director of Finance/CFO | |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Beijing TCRcure Biotechnology Co., Ltd.
 Beijing TCRcure Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing TCRcure Biotechnology Co., Ltd. develops and markets tumor immune cell therapy technology. The company is based in Beijing, China. The Chinese company was founded in 2016 by Su Frank, Li Qi-Jing, Wang Pin, Wei-Wu He. The CEO is Su Zhenpo. | Miscellaneous Commercial Services | Founder | |
| IDG Capital | Director/Board Member | ||
| LIGHT VISION CO., LTD. | Director/Board Member | ||
| Hexie Zhuorui Zhuhai Investment Management Co. Ltd. | Corporate Officer/Principal | ||
| Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | ||
Shenzhen Share Investment LP
 Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Investment Managers | Director/Board Member |
Statistics
International
| China | 32 |
| United States | 11 |
| Cayman Islands | 3 |
| France | 2 |
| Canada | 2 |
Sectoral
| Consumer Services | 14 |
| Health Technology | 11 |
| Commercial Services | 9 |
| Finance | 7 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 31 |
| Corporate Officer/Principal | 19 |
| Founder | 11 |
| Independent Dir/Board Member | 10 |
| Undergraduate Degree | 9 |
Most connected contacts
| Insiders | |
|---|---|
| Wei Wu He | 19 |
| Yue Wu | 16 |
| Zhen Bo Su | 13 |
| Alexander Zukiwski | 12 |
| Xue Bo Zeng | 10 |
| Thomas Folinsbee | 8 |
| Chun Hua Wang | 6 |
| Kun Qian | 6 |
| Fu Qiang Zhang | 5 |
| Wei Gao | 3 |
- Stock Market
- Insiders
- Wei Zhang
- Company connections
